Integrated therapy including acupuncture in a patient with long-term survival from spinal cord metastases of ALK-positive lung adenocarcinoma: a case report - Scorecard - MDSpire
Advertisement
Integrated therapy including acupuncture in a patient with long-term survival from spinal cord metastases of ALK-positive lung adenocarcinoma: a case report
Clinical Scorecard: Case Report on Long-Term Survival in an ALK-Positive Lung Adenocarcinoma Patient with Spinal Cord Metastases Treated with Integrated Acupuncture Therapy
At a Glance
Category
Detail
Condition
ALK-positive lung adenocarcinoma with spinal cord metastases
Key Mechanisms
Neurological recovery and tumor management
Target Population
Patients with spinal cord metastases from lung adenocarcinoma
Care Setting
Integrative oncology
Key Highlights
Spinal cord metastases indicate a progressed phase of lung carcinoma with poor prognosis.
Acupuncture may enhance muscle strength and quality of life in patients with SCMs.
Overall survival period from SCM diagnosis was greater than 9 months in the reported case.
Systemic treatments often fall short in addressing neurological recovery.
Acupuncture is a low-cost adjunctive therapy with minimal risk of interaction with systemic treatments.
Guideline-Based Recommendations
Diagnosis
Histological examination and molecular analysis are essential for confirming ALK-positive lung adenocarcinoma.
Management
Systemic pharmacological treatment is the primary option for managing SCMs.
Monitoring & Follow-up
Monitor neurological function and quality of life in patients with SCMs.
Risks
Secondary injury mechanisms such as inflammation and ischemia can worsen neurological outcomes.
Patient & Prescribing Data
Patients with advanced lung adenocarcinoma and spinal cord metastases
Acupuncture may serve as a beneficial adjunct to conventional therapies.
Clinical Best Practices
Incorporate acupuncture as part of a comprehensive treatment plan for SCMs.
Focus on neurological rehabilitation alongside tumor management.
